{"id":"https://openalex.org/W2260428309","doi":null,"title":"Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.","display_name":"Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells.","publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W2260428309","mag":"2260428309","pmid":"https://pubmed.ncbi.nlm.nih.gov/12813136"},"language":"en","primary_location":{"id":"pmid:12813136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12813136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102099540","display_name":"Yijiang Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yijiang Shi","raw_affiliation_strings":["Hematology-Oncology Division of the West Los Angeles VA-UCLA Medical Center, Los Angeles, California 90073, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology-Oncology Division of the West Los Angeles VA-UCLA Medical Center, Los Angeles, California 90073, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082460188","display_name":"Joseph Gera","orcid":"https://orcid.org/0000-0002-2908-6894","observed_orcids":["https://orcid.org/0000-0002-2908-6894"]},"institutions":[{"id":"https://openalex.org/I4210108215","display_name":"VA West Los Angeles Medical Center","ror":"https://ror.org/01xfgtq85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210108215","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Gera","raw_affiliation_strings":["West Los Angeles VA Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Los Angeles VA Medical Center","institution_ids":["https://openalex.org/I4210108215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009140521","display_name":"Jung-Hsin Hsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108215","display_name":"VA West Los Angeles Medical Center","ror":"https://ror.org/01xfgtq85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210108215","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jung-Hsin Hsu","raw_affiliation_strings":["West Los Angeles VA Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Los Angeles VA Medical Center","institution_ids":["https://openalex.org/I4210108215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067106221","display_name":"Brian G. Van Ness","orcid":"https://orcid.org/0000-0003-4985-2274","observed_orcids":["https://orcid.org/0000-0003-4985-2274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Van Ness","raw_affiliation_strings":["Genetics, Cell Biology and Development (TMED)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics, Cell Biology and Development (TMED)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089009048","display_name":"Alan K. Lichtenstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108215","display_name":"VA West Los Angeles Medical Center","ror":"https://ror.org/01xfgtq85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210108215","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Lichtenstein","raw_affiliation_strings":["West Los Angeles VA Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Los Angeles VA Medical Center","institution_ids":["https://openalex.org/I4210108215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8768,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.84631102,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"6","first_page":"563","last_page":"72"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.08640000224113464,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.5569999814033508},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.8270000219345093},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.9959999918937683},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8709999918937683},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.7120000123977661},{"id":"https://openalex.org/keywords/p70-s6-kinase","display_name":"p70 S6 kinase","score":0.8859999775886536},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.8560000061988831},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.9120000004768372},{"id":"https://openalex.org/keywords/low-serum-conditions","display_name":"low serum conditions","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6730777025222778},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5661159753799438},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5631837248802185},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4868907034397125},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4842926859855652},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4764010012149811},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.45230817794799805},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44906723499298096},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4295964539051056},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4220014214515686},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39883944392204285},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2556275427341461},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.23884740471839905},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10000419616699219},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0784616470336914}],"mesh":[{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011905","descriptor_name":"Genes, ras","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013778","descriptor_name":"Tetrazolium Salts","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019883","descriptor_name":"Alkyl and Aryl Transferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D038762","descriptor_name":"Ribosomal Protein S6 Kinases, 70-kDa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051231","descriptor_name":"Farnesyltranstransferase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:12813136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12813136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.903.9825","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.903.9825","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/2/6/563.full.pdf","raw_type":"text"},{"id":"pmh:oai:ir.ndhu.edu.tw:987654321/6525","doi":null,"is_oa":false,"landing_page_url":"http://ir.ndhu.edu.tw/handle/987654321/6525","pdf_url":null,"source":{"id":"https://openalex.org/S7407064279","display_name":"National Dong Hwa University Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"mag:2260428309","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12813136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1549182995","display_name":"The AKT-mTOR Pathway in Multiple Myeloma","funder_award_id":"R01CA096920","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7842815692","display_name":"Studies on Monoclonal Gammopathies","funder_award_id":"P01CA062242","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W66769261","https://openalex.org/W75558007","https://openalex.org/W84008997","https://openalex.org/W1494751477","https://openalex.org/W1521994227","https://openalex.org/W1525857207","https://openalex.org/W1526004337","https://openalex.org/W1544277307","https://openalex.org/W1568956696","https://openalex.org/W1585517331","https://openalex.org/W1587169392","https://openalex.org/W1602943807","https://openalex.org/W1604292388","https://openalex.org/W1679229316","https://openalex.org/W1923119394","https://openalex.org/W1974624332","https://openalex.org/W1976385326","https://openalex.org/W1982062664","https://openalex.org/W1985238450","https://openalex.org/W1989203819","https://openalex.org/W1993205500","https://openalex.org/W2007000374","https://openalex.org/W2011425688","https://openalex.org/W2013907250","https://openalex.org/W2025771828","https://openalex.org/W2031810333","https://openalex.org/W2041926656","https://openalex.org/W2050988292","https://openalex.org/W2051626784","https://openalex.org/W2051994734","https://openalex.org/W2052490105","https://openalex.org/W2060957113","https://openalex.org/W2061234826","https://openalex.org/W2069832196","https://openalex.org/W2090356463","https://openalex.org/W2097873933","https://openalex.org/W2101389464","https://openalex.org/W2102725664","https://openalex.org/W2125991735","https://openalex.org/W2127779890","https://openalex.org/W2145079083","https://openalex.org/W2155167738","https://openalex.org/W2163985137","https://openalex.org/W2294883787","https://openalex.org/W2319148198"],"related_works":["https://openalex.org/W7098222088","https://openalex.org/W2021120405","https://openalex.org/W2153052781","https://openalex.org/W2011944110","https://openalex.org/W2115095932","https://openalex.org/W1965072784","https://openalex.org/W2581748142","https://openalex.org/W2086394230","https://openalex.org/W2039468151","https://openalex.org/W2155167738"],"abstract_inverted_index":{"Farnesyl":[0],"transferase":[1],"inhibitors":[2,206],"(FTIs)":[3],"are":[4,20,48,71],"anticancer":[5],"agents":[6,32],"designed":[7],"to":[8,24,50,94,229],"target":[9,99],"ras":[10,18,84,148,271],"processing":[11],"and":[12,126,169,181,199,240,252,258],"ras-dependent":[13],"signal":[14,173],"pathways.":[15],"Because":[16,80],"oncogenic":[17],"mutations":[19],"found":[21],"in":[22,36,58,103,110,123,175,187,192,221,264,280],"up":[23],"50%":[25],"of":[26,82,118,140,147,166,235,246,249,256,260,278],"multiple":[27],"myeloma":[28,64,119],"(MM)":[29],"specimens,":[30],"these":[31,217],"may":[33],"be":[34],"effective":[35],"this":[37,56,89,241,281],"disease.":[38,282],"However,":[39,138,191],"some":[40],"preclinical":[41],"studies":[42,193],"suggest":[43],"that":[44],"FTI":[45],"antitumor":[46],"responses":[47],"unrelated":[49],"effects":[51,215],"on":[52,155,216],"ras.":[53],"To":[54],"address":[55],"issue":[57],"myeloma,":[59],"we":[60,211],"used":[61],"the":[62,167,222,231,261,275],"ANBL-6":[63],"cell":[65],"line":[66],"where":[67,194],"interleukin":[68],"(IL)-6-dependent":[69],"cells":[70,120,129,266],"stably":[72],"transfected":[73],"with":[74,145,244],"mutated":[75,83,127,177,188,268],"N-ras":[76],"or":[77,207,269],"K-ras":[78],"genes.":[79],"expression":[81],"allows":[85],"for":[86,274],"IL-6-independent":[87],"growth,":[88],"is":[90],"a":[91],"good":[92],"model":[93],"test":[95],"whether":[96],"FTIs":[97,115,162,225,279],"specifically":[98],"growth-promoting":[100],"ras-activated":[101],"pathways":[102,218],"myeloma.":[104],"Although":[105,150],"they":[106,151],"had":[107,152],"little":[108],"effect":[109,154],"10%":[111],"serum,":[112,125],"two":[113],"separate":[114],"induced":[116],"apoptosis":[117,141,257],"when":[121],"cultured":[122],"low":[124,159],"ras-expressing":[128,136,178,237],"were":[130,201,226],"more":[131],"sensitive":[132],"than":[133],"wild-type":[134],"(WT)":[135],"cells.":[137,190],"induction":[139,255],"did":[142],"not":[143,213],"correlate":[144],"inhibition":[146,245],"processing.":[149],"no":[153],"AKT":[156],"activity,":[157],"under":[158],"serum":[160],"conditions":[161],"inhibited":[163,203],"constitutive":[164],"activation":[165,248],"p70S6kinase":[168],"nuclear":[170,196],"factor":[171,197],"kappaB":[172],"proteins":[174],"both":[176],"MM":[179,238,265],"lines":[180],"extracellular":[182],"signal-regulated":[183],"kinase":[184],"(ERK)":[185],"activity":[186],"N-ras-expressing":[189],"p70,":[195],"kappaB,":[198],"ERK":[200],"comparably":[202],"by":[204,208],"other":[205],"gene":[209],"transfer,":[210],"could":[212],"identify":[214],"as":[219],"participating":[220],"apoptotic":[223],"response.":[224],"also":[227],"able":[228],"abrogate":[230],"IL-6":[232,262],"proliferative":[233],"response":[234,263],"WT":[236,270],"cells,":[239],"was":[242],"associated":[243],"IL-6-induced":[247],"ERK,":[250],"AKT,":[251],"p70.":[253],"The":[254],"prevention":[259],"containing":[267],"provide":[272],"support":[273],"therapeutic":[276],"potential":[277]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}